Life Technologies drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (9)
Papers in which this entity is mentioned.
- Prenatal Adversity Alters the Epigenetic Profile of the Prefrontal Cortex: Sexually Dimorphic Effects of Prenatal Alcohol Exposure and Food-Related Stress. (2021)
- Genetic compensation triggered by mutant mRNA degradation. (2019)
- Ethanol activates immune response in lymphoblastoid cells. (2019)
- Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma. (2017)
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
- A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease. (2016)
- Spatial reconstruction of single-cell gene expression data. (2015)
- Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. (2013)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| life technologies | drug | 20 | 21 |
| life technologies, inc. | drug | — | — |